INR:4236. t shirt full sleeve Huadao Bio completed nearly 200 million yuan in Series C financing Livzon Microspheres have become a billion-dollar product. New ...

Snow blankets the farm fields at Merck Forest & Farmland Center as our tiny car creeps up the hill toward Joy Green Visitor’s ...

She has personally tested nearly 500 bags, jeans, bras, shoes, and more. We’ve added two new white T-shirts worth considering, Uniqlo’s Crew Neck T-Shirt and Mini T-Shirt. A great white T ...

INR:0980. football jersey t shirt Zhengda Tianqing and Dongyang Sunshine Pharmaceuticals are competing against Merck's 900 million glucose-lowering drugs!

Laïd Zerhouni had a night to remember at KSW 101, the final event of the year for Poland’s KSW promotion. Held in Nanterre, France, the event delivered action-packed fights, but it was Zerhouni’s ...

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...

Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...

RAHWAY, N.J., December 18, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced ...